SEC Filing Form 4

Patrick D. Walsh, a director at ANI Pharmaceuticals Inc. (ANIP), reported the sale of 3,973 shares of common stock on May 11, 2026, for $80.75 per share. This transaction reduced his post-transaction holdings to 48,432 shares. Subsequently, on May 13, 2026, Walsh sold an additional 10,000 shares of common stock at $80.63 per share, leaving him with 38,432 shares. These transactions were executed under transaction code "S", indicating a sale, and were directly held by Mr. Walsh.